Opinions The Panic-Proof Portfolio (Stockchase Research)
TG TherapeuticsTGTXTOP PICKOct 22, 2026
$53.16
Stock price when the opinion was issued
$54.17
As of Oct 23, 2026. Market Open.
biotechnology
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
You might be interested:
BUY
Developing drugs for MS and blood cancers like leukemia. Exciting prospects; boasts promising clinical trial results, especially for their MS drug. Last month, they announced good phase 3 results for that drug which lifted share from the $30's to $50's. Cash flow is fine; they just said they've raised a lot of money.
biotechnology
The developer of a medication for relapsing MS in patients has seen an 88% reduction in progression after seven years of usage. It trades at 13x earnings and supports a 100% ROE. We like that quarterly cash reserves are growing along with cash flow. We recommend setting a stop-loss at $41, looking to achieve $70 -- upside potential of 30%. Yield 0%
(Analysts’ price target is $69.70)